Frontlight ResearchEarly access
Trial site
Ann Arbor
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Asthma2 trials
- Colorectal cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Lupus (SLE)1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Systemic sclerosis (scleroderma)1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- GlaxoSmithKline9 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry
Site data: ClinicalTrials.govUpdated 14 Nov 2026